Global Monoclonal Antibodies Market 2023 to 2033: Players Include Merck & Co, Abbott Laboratories, Biogen and AstraZeneca - ResearchAndMarkets.com
The "Monoclonal Antibodies Market by Source Type, Production Type, Application, End Use, and by Region - Global Forecast to 2022-2033" report has been added to ResearchAndMarkets.com's offering.
- The "Monoclonal Antibodies Market by Source Type, Production Type, Application, End Use, and by Region - Global Forecast to 2022-2033" report has been added to ResearchAndMarkets.com's offering.
- The monoclonal antibodies market size is estimated to be USD 189,432 million in 2022 and is expected to witness a CAGR of 11.42% during the forecast period 2023-2033.
- Strategic initiatives performed by top companies for the development of mAb products is expected to drive the market.
- For instance, Atlas Antibodies AB and T-Cure Bioscience, Inc. collaborated together to produce and supply CT83 mAbs in October 2021.